You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 3, March 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Neurology, Other
 •Genetic Disorders
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neuromics

Roger N. Rosenberg, MD, Editor

Arch Neurol. 2008;65(3):304.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Our call for papers for this special theme issue resulted in a vigorous and robust response. In this issue and the April issue of Archives, clinical and molecular neurogenetics and neuromics—the genomic analyses of neurological disorders and functions—are represented by truly outstanding scientific presentations covering a wide array of subjects by world-class authorities in the field. We are most grateful for their support. The diversity of articles includes genome whole-array analyses for Alzheimer disease and multiple sclerosis, providing a neuromic perspective. Neurological review topics include gene-targeted therapies; retromer gene polymorphisms and Alzheimer disease; a HapMap analysis; stem cells and neurological disease; and defining the tau and progranulin mutations causing frontotemporal disease.

Original scientific contributions included in either the March or April issues cover interferon gamma polymorphisms and risk of multiple sclerosis; early-onset inherited Alzheimer disease due to Arctic amyloid precursor protein gene mutations; progranulin . . . [Full Text of this Article]

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.